BORGIANI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 36.887
AS - Asia 4.039
EU - Europa 3.838
SA - Sud America 588
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 9
Totale 45.447
Nazione #
US - Stati Uniti d'America 36.756
SG - Singapore 1.949
CN - Cina 814
DE - Germania 563
IT - Italia 563
BR - Brasile 500
RU - Federazione Russa 473
UA - Ucraina 453
VN - Vietnam 379
IE - Irlanda 372
FR - Francia 347
HK - Hong Kong 315
PL - Polonia 259
GB - Regno Unito 255
SE - Svezia 179
FI - Finlandia 168
JP - Giappone 133
KR - Corea 94
CA - Canada 81
IN - India 60
NL - Olanda 51
TR - Turchia 45
AR - Argentina 35
BD - Bangladesh 35
BE - Belgio 32
ID - Indonesia 32
MX - Messico 32
ZA - Sudafrica 31
KG - Kirghizistan 29
IR - Iran 23
UZ - Uzbekistan 23
AT - Austria 22
CZ - Repubblica Ceca 21
IQ - Iraq 21
ES - Italia 20
MA - Marocco 13
PK - Pakistan 12
EU - Europa 11
LT - Lituania 10
CO - Colombia 9
EC - Ecuador 9
CH - Svizzera 8
PY - Paraguay 8
RO - Romania 8
VE - Venezuela 8
AU - Australia 7
CL - Cile 7
MY - Malesia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
DZ - Algeria 6
PE - Perù 6
PH - Filippine 6
SA - Arabia Saudita 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
IL - Israele 5
NP - Nepal 5
PT - Portogallo 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
AL - Albania 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
QA - Qatar 3
RS - Serbia 3
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
DM - Dominica 2
IS - Islanda 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
Totale 45.440
Città #
Woodbridge 9.832
Wilmington 9.462
Houston 8.592
Fairfield 1.197
Singapore 1.123
Ann Arbor 737
Ashburn 716
Chandler 643
San Jose 442
Seattle 432
Cambridge 389
New York 374
Jacksonville 366
Beijing 351
Dublin 344
Hong Kong 309
Medford 260
Rome 217
Kraków 215
The Dalles 184
Dallas 160
Dearborn 159
Santa Clara 148
Council Bluffs 138
Los Angeles 136
Lawrence 120
Boardman 113
Ho Chi Minh City 106
Tokyo 106
Hanoi 102
Menlo Park 94
Lauterbourg 90
Moscow 72
Buffalo 69
San Diego 61
São Paulo 61
Helsinki 60
Munich 54
London 44
Zhengzhou 37
Warsaw 34
Chicago 33
Milan 33
Redwood City 33
Palo Alto 30
Atlanta 28
Montreal 28
Orem 28
Toronto 28
Shanghai 27
Mülheim 26
Norwalk 26
Brussels 25
Da Nang 25
Nuremberg 25
Phoenix 24
Denver 23
Mountain View 23
North Bergen 23
Frankfurt am Main 22
Hefei 22
Redondo Beach 22
Chennai 21
Jakarta 21
Johannesburg 21
Brooklyn 19
Stockholm 18
University Park 17
Haiphong 16
Seoul 16
Ankara 15
Poplar 15
Tashkent 15
Nanjing 14
San Francisco 14
Amsterdam 13
Belo Horizonte 13
Kunming 13
Lappeenranta 13
Manchester 12
Olomouc 12
Vienna 12
Detroit 11
Dhaka 11
Hangzhou 11
Hải Dương 11
Istanbul 11
Querétaro 11
Brasília 10
Columbus 10
Guangzhou 10
Verona 10
Boston 9
Charlotte 9
Mexico City 9
Philadelphia 9
Rio de Janeiro 9
Turku 9
Baghdad 8
Creede 8
Totale 39.189
Nome #
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 534
High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase 518
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 510
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 502
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians 493
A family study of asymptomatic small bowel Crohn's disease 493
Age-related macular degeneration: insights into inflammatory genes 488
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 486
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 485
Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease 485
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 483
A Pharmacogenetics Study in Mozambican Patients Treated with Nevirapine: Full Resequencing of TRAF3IP2 Gene Shows a Novel Association with SJS/TEN Susceptibility 483
Advances in exploring the role of micrornas in inflammatory bowel disease 480
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population 478
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene 477
Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice 471
Intrauterine development and MNSs blood groups in repeated spontaneous abortion. 470
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 466
Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique 465
Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01 464
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study 464
A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus 461
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 457
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms 456
Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient 454
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons syndrome/toxic epidermal necrolysis susceptibility in a population from Mozambique 453
Crohn's disease, the mycobacterium paratuberculosis and the genetic bond: An unexpected trio 453
Foetal macrosomia and erythrocyte acid phosphatase (ACP1) polymorphism in diabetic and normal pregnancy. 451
Comparative analysis between saliva and buccal swabs as source of DNA: Lesson from HLA-B∗57:01 testing 449
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction 449
Role of genetics in prevention of coronary atherosclerosis 447
Interleukin-23R Arg381Gln Is Associated With Susceptibility to Crohn's Disease But Not With Phenotype in an Italian Population 446
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 445
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 442
Association of the ACP1 genotype with metabolic parameters upon initial diagnosis of type 1 diabetes. 441
FLG (filaggrin) null mutations and sunlight exposure: Evidence of a correlation 441
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 439
Biomarkers to predict drug efficacy and safety in neurodegenerative diseases 438
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. 438
Pharmacogenomics of multifactorial diseases: A focus on psoriatic arthritis 437
Cannabinoid Poisoning by Hemp Seed Oil in a Child 437
Association between ACP(1) and favism: A possible biochemical mechanism 436
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development 435
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 431
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 430
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 429
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis 428
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase 427
Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population 426
Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy 425
Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM 424
Phosphotyrosine-protein-phosphatase and diabetic disorders. Further studies on the relationship between low molecular weight acid phosphatase genotype and degree of glycemic control 420
Acid phosphatase locus 1 (ACP1): Possible relationship of allelic variation to body size and human population adaptation to thermal stress - A theoretical perspective 420
Identification of two SNPs in the 5' flanking region of the ACP1 gene and evaluation of disequilibrium among polymorphic sites. 420
Two molecular assays for the rapid and inexpensive detection of GJB2 and GJB6 mutations 419
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease 418
Recent advances in the genetic susceptibility to osteoarthritis 418
Neonatal screening, clinical features and genetic testing for galactosemia [3] 417
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 417
Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. 416
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 415
MicroRNA genetic variations: association with type 2 diabetes 411
IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs 410
EPHX1 Polymorphisms Are Not Associated With Warfarin Response in an Italian Population 410
ABCC10 rs2125739 polymorphism and nevirapine-induced hepatotoxicity: lack of association in a population from Mozambique 410
Phosphoglucomutase genetic polymorphism of newborns 409
RH blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level? 407
A study of human growth hormone and insulin gene regions in relation to metabolic control of non-insulin-dependent diabetes mellitus 404
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 402
Correction: A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics 402
Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases 400
L’impatto sulla salute umana dell’arsenico presente in basse concentrazioni nelle acque. Proposta di uno studio caso controllo Nested nell’area del viterbese 398
Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction 397
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 397
Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes 395
OLR1 gene and coronary artery disease/acute myocardial infarction: Replication in an independently collected sample [1] 392
Rh blood groups and diabetic disorders 392
Low molecular weight PTP-IL-4RA interaction in atopy predisposition 390
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 389
New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases [Nuovi approfondimenti nella ricerca su l'ateroslerosi: LOX-1, un primo attore nelle malattie cardiovascolari] 387
Genetic tests and genomic biomarkers: regulation, qualification and validation 387
Pharmacogenomics: role in medicines approval and clinical use 385
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 376
Foetal macrosomia in diabetic pregnancy. Further data on the association with maternal PGM1 genotype 371
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 362
Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility 361
Pharmacogenetics of inflammatory bowel disease: A focus on Crohn's disease 361
Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic Studies 358
Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. 343
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population 327
A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine 323
Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility 308
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 307
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects 290
Interaction between microbiome and host genetics in psoriatic arthritis 285
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes 271
Pharmacogenomics in Parkinson's disease: which perspective for developing a personalized medicine? 265
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 260
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals 255
COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells 218
Totale 41.615
Categoria #
all - tutte 104.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021446 0 0 0 0 0 0 0 0 0 157 220 69
2021/20221.359 75 134 60 83 52 145 67 55 125 122 104 337
2022/20231.653 171 142 47 232 158 383 142 91 137 20 85 45
2023/2024848 84 19 40 24 47 331 34 41 12 8 16 192
2024/20253.011 91 672 308 226 59 125 222 182 340 278 229 279
2025/20264.998 504 204 654 545 526 210 692 570 586 507 0 0
Totale 45.964